Keytruda’s Breakthrough and Global Access Gap
A yearlong international investigation into one of the world's most important cancer drugs shows how a medical breakthrough has also become a fault line in global health, exposing how pricing systems, patent protections and regulatory frameworks determine who can access life-saving treatment and who cannot. The Cancer Calculus, coordinated by the International Consortium of Investigative Journalists